Delivery Order SPE2DX22D0010-SPE2D825FFZ25
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $51,279.17 delivery order to AmerisourceBergen Drug Corp for 36-milligram Concerta ER tablets under a firm fixed-price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta 36mg, with a ceiling value of $3,715.96. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. The delivery order represents a single pharmaceutical procurement transaction under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets valued at $14,709.30 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $4,441.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Concerta HCL 18mg tablets (100-count units). This is a non-set-aside competitive award with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $9,033.73. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $34.3K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1B and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $45,836.39 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,857.38 to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FFZ25Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $15.5K delivery order to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets, with a completion date of June 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. This delivery order represents a small transaction within AmerisourceBergen's broader $1 billion pharmaceutical supply vehicle with DLA, which runs through December 2026 and enables the company to supply a comprehensive range of pharmaceuticals and medical commodities to support military healthcare programs globally. Concerta ER is a commonly prescribed attention-deficit/hyperactivity disorder (ADHD) medication, indicating this delivery supports pharmaceutical needs within the Defense Health Agency or related military medical systems. AmerisourceBergen's role as a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program demonstrates its established capacity to meet federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 5/30/25 |